Regulatory and Clinical Experiences With Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada
Oncologist - United States
doi 10.1634/theoncologist.2018-0341
Full Text
Open PDFAbstract
Available in full text
Date
March 6, 2019
Authors
Publisher
Alphamed Press